Cofepris consolidates DIGIPRiS platform: digital income procedures with automatic resolution
The Federal Commission for the Protection against Sanitary Risks (Cofepris) consolidates DIGIPRiS, a digital platform with which...
Cofepris alerts for the illegal sale of antivirals for Covid-19
Cofepris, the FDA, and other authorities recommend avoiding acquiring this type of medication on the illegal market...
COFEPRIS alert on falsified sclerosis medicine
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) issued an alert about the counterfeiting of...
Mexico-US collaboration in science and innovation consolidates collective capacities: Hugo López-Gatell
The collaboration between Mexico and the United States in science, innovation, development, technology, and health has a...
COFEPRIS presents a new Virtual Judgment Unit
Authorities of the Federal Commission for the Protection against Sanitary Risks (COFEPRIS) received a delegation from the...
INSABI detects 51 companies that distribute counterfeit medicines to the health sector
The general director of the Health Institute for Welfare (INSABI), Juan Antonio Ferrer Aguilar, assured that the...
COFEPRIS warns about counterfeit drugs against cancer and types 2 diabetes
The Federal Commission for the Protection against Sanitary Risks (COFEPRIS) issued an alert about the counterfeiting of...
COFEPRIS attends 219 technical sessions for the pharmaceutical sector
COFEPRIS reported that it had attended 219 technical sessions from January to August this year, focusing on...
Clinical laboratories in Mexico strengthen strategies for drug development and access
The Ministry of Health of Mexico highlighted that the National Network of Public Health Laboratories had become...
The Ministry of Health and Navy create in Mexico Intelligence Center against Sanitary Risks
The Ministry of Health, through the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), and the...